Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61)

Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999; 20: 189–206. Lau LF, Lam SC. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 1999; 248: 44–57. Perbal B. The CCN family of genes: A brief history. Mol Pathol 2001; 54: 103–4. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: Structural and functional issues. Mol Pathol 2001; 54: 57–79. Latinkic BV, O'Brien TP, Lau LF. Promoter function and structure of the growth factor-inducible immediate early gene cyr61. Nucleic Acids Res 1991; 19: 3261–7. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993; 327: 125–30. Grotendorst GR. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171–9. Moussad EE, Brigstock DR. Connective tissue growth factor: What's in a name? Mol Genet Metab 2000; 71: 276–92. Bornstein P. Matricellular proteins: An overview. Matrix Biol 2000; 19: 555–6. Bornstein P, Sage EH. Matricellular proteins: Extracellular modulators of cell function. Curr Opin Cell Biol 2002; 14: 608–16. Lukashev ME, Werb Z. ECM signalling: Orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998; 8: 437–41. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996; 7: 469–80. Martinerie C, Viegas-Pequignot E, Nguyen VC et al. Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Pathol 1997; 50: 310–6. Lau LF, Nathans D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 1985; 4: 3145–51. Brunner A, Chinn J, Neubauer M et al. Identification of a gene family regulated by transforming growth factor-beta. DNA Cell Biol 1991; 10: 293–300. Almendral JM, Sommer D, Macdonald-Bravo H et al. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 1988; 8: 2140–8. Ryseck RP, Macdonald-Bravo H, Mattei MG et al. Structure, mapping,and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ 1991; 2: 225–33. Igarashi A, Okochi H, Bradham DM et al. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4: 637–45. Kothapalli D, Frazier KS, Welply A et al. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ 1997; 8: 61–8. Duncan MR, Frazier KS, Abramson S et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP. FASEB J 1999; 13: 1774–86. Holmes A, Sa S, Shiwen X et al. CTGF and SMADs: Maintenance of scleroderma phenotype is independent of SMAD signalling. J Biol Chem 2001; 276: 10594–601. Leask A, Sa S, Holmes A et al. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 2001; 54: 180–3. Brigstock DR. Purification and characterization of connective tissue growth factor (CTGF) using heparin-affinity chromatography. In Aboul-Enein HY (ed): Analytical and Preparative Separation Methods of Biomacromolecules, New York: Marcel Dekker 1999; 397–414. Brigstock DR, Steffen CL, Kim GY et al. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 1997; 272: 20275–82. Chen N, Chen CC, Lau LF. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans. J Biol Chem 2000; 275: 24953–61. Ball DK, Moussad EE, Rageh MA et al. Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero. Reproduction 2003; 125: 271–84. Ball DK, Wilson AW, Kemper SA et al. The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol 2003; 176: R1–7. Chen CC, Chen N, Lau LF. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 2001; 276: 10443–52. Kireeva ML, Latinkic BV, Kolesnikova TV et al. Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism,and localization during development. Exp Cell Res 1997; 233: 63–77. Ball DK, Surveyor GA, Diehl JR et al. Characterization of 16-to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings. Biol Reprod 1998; 59: 828–35. Yang DH, Kim HS, Wilson EM et al. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab 1998; 83: 2593–6. Boes M, Dake BL, Booth BA et al. Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells. Endocrinology 1999; 140: 1575–80. Bradham DM, Igarashi A, Potter RL et al. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285–94. Kim HS, Nagalla SR, Oh Y et al. Identification of a family of lowaffinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 1997; 94: 12981–6. Kolesnikova TV, Lau LF. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 1998; 16: 747–54. Wunderlich K, Senn BC, Todesco L et al. Regulation of connective tissue growth factor gene expression in retinal vascular endothelial cells by angiogenic growth factors. Graefes Arch Clin Exp Ophthalmol 2000; 238: 910–5. Suzuma K, Naruse K, Suzuma I et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR,Flt1,and phosphatidylinositol 3-kinase-aktdependent pathways in retinal vascular cells. J Biol Chem 2000; 275: 40725–31. Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 2001; 4: 289–98. Lin J, Liliensiek B, Kanitz M et al. Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells,fibroblasts and smooth muscle cells. Cardiovasc Res 1998; 38: 802–13. Shimo T, Nakanishi T, Nishida T et al. Involvement of CTGF,a hypertrophic chondrocyte-specific gene product,in tumor angiogenesis. Oncology 2001; 61: 315–22. Shimo T, Nakanishi T, Kimura Y et al. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (Tokyo) 1998; 124: 130–40. Kireeva ML, Mo FE, Yang GP et al. Cyr61,a product of a growth factor-inducible immediate-early gene,promotes cell proliferation,migration, and adhesion. Mol Cell Biol 1996; 16: 1326–34. Yang GP, Lau LF. Cyr61,produc t of a growth factor-inducible immediate early gene,is associated with the extracellular matrix and the cell surface. Cell Growth Differ 1991; 2: 351–7. Klagsbrun M. Mediators of angiogenesis: The biological signi-ficance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol 1992; 3: 81–7. Rusnati M, Presta M. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int J Clin Lab Res 1996; 26: 15–23. Shimo T, Nakanishi T, Nishida T et al. Connective tissue growth factor induces the proliferation,migration,and tube formation of vascular endothelial cells in vitro,and angiogenesis in vivo. J Biochem (Tokyo) 1999; 126: 137–45. Frazier K, Williams S, Kothapalli D et al. Stimulation of fibroblast cell growth,matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404–11. Kireeva ML, Lam SC, Lau LF. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J Biol Chem 1998; 273: 3090–6. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration CTGF and CYR61 in angiogenesis 163 through integrin alphavbeta3,promote s endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19: 2958–66. Babic AM, Kireeva ML, Kolesnikova TV et al. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 1998; 95: 6355–60. Tsai MS, Hornby AE, Lakins J et al. Expression and function of CYR61,an angiogenic factor,in breast cancer cell lines and tumor biopsies. Cancer Res 2000; 60: 5603–7. Inoki I, Shiomi T, Hashimoto G et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 2002; 16: 219–21. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 2002; 277: 46248–55. Kondo S, Kubota S, Shimo T et al. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002; 23: 769–76. Jedsadayanmata A, Chen CC, Kireeva ML et al. Activationdependent adhesion of human platelets to Cyr61 and Fisp12/ mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 1999; 274: 24321–7. Schober JM, Chen N, Grzeszkiewicz TM et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): Immediate-early gene products expressed in atherosclerotic lesions. Blood 2002; 99: 4457–65. Grzeszkiewicz TM, Lindner V, Chen N et al. The angiogenic factor cysteine-rich 61 (CYR61,CCN1 ) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 2002; 143: 1441–50. Grzeszkiewicz TM, Kirschling DJ, Chen N et al. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem 2001; 276: 21943–50. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995; 268: 233–9. Hishikawa K, Oemar BS, Tanner FC et al. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 1999; 274: 37461–6. Hishikawa K, Oemar BS, Tanner FC et al. Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999; 100: 2108–12. Hishikawa K, Nakaki T, Fujii T. Connective tissue growth factor induces apoptosis via caspase 3 in cultured human aortic smooth muscle cells. Eur J Pharmacol 2000; 392: 19–22. Hishikawa K, Nakaki T, Fujii T. Transforming growth factorbeta( 1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur J Pharmacol 1999; 385: 287–90. Yoshisue H, Suzuki K, Kawabata A et al. Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. Atherosclerosis 2002; 162: 323–34. Garcia-Cardena G, Comander J, Anderson KR et al. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA 2001; 98: 4478–85. Uzumcu M, Homsi MF, Ball DK et al. Localization of connective tissue growth factor in human uterine tissues. Mol Hum Reprod 2000; 6: 1093–8. Moussad EE, Rageh MA, Wilson AK et al. Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the uteroplacental interface during early pregnancy in the pig. Mol Pathol 2002; 55: 186–92. Wandji SA, Gadsby JE, Barber JA et al. Messenger ribonucleic acids for MAC25 and connective tissue growth factor (CTGF) are inversely regulated during folliculogenesis and early luteogenesis. Endocrinology 2000; 141: 2648–57. Ito Y, Aten J, Bende RJ et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998; 53: 853–61. Kasaragod AB, Lucia MS, Cabirac G et al. Connective tissue growth factor expression in pediatric myofibroblastic tumors. Pediatr Dev Pathol 2001; 3: 37–45. St Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium. Science 2000; 289: 1197–202. Igarashi A, Nashiro K, Kikuchi K et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995; 105: 280–4. Oemar BS, Werner A, Garnier JM et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997; 95: 831–9. Hilfiker A, Hilfiker-Kleiner D, Fuchs M et al. Expression of CYR61,an angiogenic immediate early gene,in arteriosclerosis and its regulation by angiotensin II. Circulation 2002; 106: 254–60. Surveyor GA, Wilson AK, Brigstock DR. Localization of connective tissue growth factor during the period of embryo implantation in the mouse. Biol Reprod 1998; 59: 1207–13. O'Brien TP, Lau LF. Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ 1992; 3: 645–54. Latinkic BV, Mo FE, Greenspan JA et al. Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: Tissue specificity,inducib ility during wound healing,and role of the serum response element. Endocrinology 2001; 142: 2549–57. Surveyor GA, Brigstock DR. Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. Growth Factors 1999; 17: 115–24. Folkman J. Angiogenesis in cancer,vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31. Shimo T, Kubota S, Kondo S et al. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 2001; 174: 57–64. Chen CC, Mo FE, Lau LF. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 2001; 276: 47329–37. Xie D, Miller CW, O'Kelly J et al. Breast cancer. Cyr61 is overexpressed,estrogen-indu cible,and associated with more advanced disease. J Biol Chem 2001; 276: 14187–94. Walker TM, Van Ginkel PR, Gee RL et al. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol 2002; 120: 1719–25. Igarashi A, Hayashi N, Nashiro K et al. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. J Cutan Pathol 1998; 25: 143–8. Pan LH, Beppu T, Kurose A et al. Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol Res 2002; 24: 677–83. Rubenstein J, Shen A, Haqq C et al. Connective tissue growth factor is expressed in malignant astrocytic tumors and is involved in cell-cycle regulation. Mol Pathol, in press. Frazier KS, Grotendorst GR. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 1997; 29: 153–61. Leask A, Holmes A, Abraham DJ. Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep 2002; 4: 136–42. Uzel MI, Kantarci A, Hong HH et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001; 72: 921–31. Dammeier J, Brauchle M, Falk W et al. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909–22. Williams EJ, Gaca MD, Brigstock DR et al. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol 2000; 32: 754–61. Paradis V, Dargere D, Bonvoust F et al. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 2002; 82: 767–74. Paradis V, Dargere D, Vidaud M et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999; 30: 968–76. Abou-Shady M, Friess H, Zimmermann A et al. Connective tissue growth factor in human liver cirrhosis. Liver 2000; 20: 296–304. O'Brien ER, Garvin MR, Dev R et al. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994; 145: 883–94. Wu KJ, Yee A, Zhu NL et al. Characterization of differential gene expression in monkey arterial neointima following balloon catheter injury. Int J Mol Med 2000; 6: 433–40. Ohnishi H, Oka T, Kusachi S et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol 1998; 30: 2411–22. Mori R, Kondo T, Ohshima T et al. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 2002; 16: 963–74. Wang JF, Olson ME, Reno CR et al. Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res 2000; 41: 195–211. Wang JF, Olson ME, Reno CR et al. The pig as a model for excisional skin wound healing: Characterization of the molecular and cellular biology, and bacteriology of the healing process. Comp Med 2001; 51: 341–49. Schwab JM, Beschorner R, Nguyen TD et al. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes,invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrauma 2001; 18: 377–88. Ujike K, Shinji T, Hirasaki S et al. Kinetics of expression of connective tissue growth factor gene during liver regeneration after partial hepatectomy and D-galactosamine-induced liver injury in rats. Biochem Biophys Res Commun 2000; 277: 448–54. Nathans D, Lau LF, Christy B et al. Genomic response to growth factors. Cold Spring Harb Symp Quant Biol 1988; 53: 893–900. Fataccioli V, Abergel V, Wingertsmann L et al. Stimulation of angiogenesis by cyr61 gene: A new therapeutic candidate. Hum Gene Ther 2002; 13: 1461–70. Mo FE, Muntean AG, Chen CC et al. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 2002; 22: 8709–20. Ivkovic S, Yoon BS, Popoff SN et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003 (in press). Burren CP, Wilson EM, Hwa V et al. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH),an additional member of the IGFBP Superfamily. J Clin Endocrinol Metab 1999; 84: 1096–103. Grotendorst GR, Lau LF, Perbal B. CCN proteins are distinct from,and should not be considered members of,the insulin-like growth factor-binding protein superfamily. J Clin Endocrinol Metab 2001; 86: 944–5. Hashimoto G, Inoki I, Fujii Y et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002; 277: 36288–95. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001; 89: 1104–10.